|

Teclistamab (Tec) Clinical Trials

4 actively recruiting trials

Also known as: JNJ-64007957

Pipeline

Phase 2: 3

Top Sponsors

  • Peking Union Medical College Hospital2
  • University of Heidelberg Medical Center1
  • Peking University People's Hospital1

Indications

  • Cancer4
  • AL Amyloidosis3
  • Multiple Myeloma1

Other4 trials

GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
Phase 2
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
N/A
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
Phase 2
Teclistamab in Previously Treated AL Amyloidosis
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.